Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Aebischer

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
JAMA Network Open|January 20, 2022
Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical TrialSophia Liu, Davide D'Amico, Eric Shankland, et al.
Nature Metabolism|July 23, 2020
The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humansPénélope A Andreux, William Blanco-Bose, Dongryeol Ryu, et al.
Journal of Neuroscience Methods|April 3, 2007
Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapyElizabeth E Capowski, Bernard L Schneider, Allison D Ebert, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 26, 2008
Dysregulation of gene expression in primary neuron models of Huntington's disease shows that polyglutamine-related effects on the striatal transcriptome may not be dependent on brain circuitryHeike Runne, Etienne Régulier, Alexandre Kuhn, et al.
Human Molecular Genetics|January 6, 2017
Parkin functionally interacts with PGC-1α to preserve mitochondria and protect dopaminergic neuronsLu Zheng, Nathalie Bernard-Marissal, Norman Moullan, et al.
Human Molecular Genetics|December 17, 2008
Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's diseaseSamareh Azeredo da Silveira, Bernard L Schneider, Carmen Cifuentes-Diaz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 29, 2013
Synergistic effects of GDNF and VEGF on lifespan and disease progression in a familial ALS rat modelDan Krakora, Patrick Mulcrone, Michael Meyer, et al.
Cell Reports. Medicine|May 18, 2022
Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adultsAnurag Singh, Davide D'Amico, Pénélope A Andreux, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 22, 2002
Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degenerationStephane Palfi, Liza Leventhal, Yaping Chu, et al.
Experimental Neurology|December 31, 2003
Long-term lentiviral-mediated expression of ciliary neurotrophic factor in the striatum of Huntington's disease transgenic miceDiana Zala, Jean-Charles Bensadoun, Luis Pereira de Almeida, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
JAMA Network Open|January 20, 2022
Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical TrialSophia Liu, Davide D'Amico, Eric Shankland, et al.
Nature Metabolism|July 23, 2020
The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humansPénélope A Andreux, William Blanco-Bose, Dongryeol Ryu, et al.
Journal of Neuroscience Methods|April 3, 2007
Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapyElizabeth E Capowski, Bernard L Schneider, Allison D Ebert, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 26, 2008
Dysregulation of gene expression in primary neuron models of Huntington's disease shows that polyglutamine-related effects on the striatal transcriptome may not be dependent on brain circuitryHeike Runne, Etienne Régulier, Alexandre Kuhn, et al.
Human Molecular Genetics|January 6, 2017
Parkin functionally interacts with PGC-1α to preserve mitochondria and protect dopaminergic neuronsLu Zheng, Nathalie Bernard-Marissal, Norman Moullan, et al.
Human Molecular Genetics|December 17, 2008
Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's diseaseSamareh Azeredo da Silveira, Bernard L Schneider, Carmen Cifuentes-Diaz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 29, 2013
Synergistic effects of GDNF and VEGF on lifespan and disease progression in a familial ALS rat modelDan Krakora, Patrick Mulcrone, Michael Meyer, et al.
Cell Reports. Medicine|May 18, 2022
Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adultsAnurag Singh, Davide D'Amico, Pénélope A Andreux, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 22, 2002
Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degenerationStephane Palfi, Liza Leventhal, Yaping Chu, et al.
Experimental Neurology|December 31, 2003
Long-term lentiviral-mediated expression of ciliary neurotrophic factor in the striatum of Huntington's disease transgenic miceDiana Zala, Jean-Charles Bensadoun, Luis Pereira de Almeida, et al.
Pageof 10